A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer

Name: A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer
Published: 2026
License: Public Domain

Anhui Provincial Cancer Hospital · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

advanced gastric cancer, tas-102, apatinib, interventional, na

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer

Related documents